Navigation
Medical Sceince & Health

Characterization and Bioanalysis of Biotherapeutic Large Molecules 

Biologics, such as monoclonal antibodies, is the emerging area of new drug development, and its future is promising. 

Structural characterization of protein drugs by LC-MS technology may provide extensive sequential structure information, 

and also quantitative results with extremely high selectivity and specificity that traditional approaches,

such as, immunoassay are unreachable. Large molecules LC-MS technology is our unique and key value, 

with which we are able to service our clients’ challenging projects in large molecules characterization and bioanalysis, 

providing unmatchable results:

  Structure Characterization of Protein Drugs  

  High Selective Protein Drug Bioanalysis  


Small Molecules Bioanalysis

SSR MedTech has very experienced bioanalytical team, 

and is capable of providing LC-MS bioanalytical solutions for clients’most challenging projects to support generic drugs 

BE clinical studies and new drug development in every stage of preclinical and clinical trials. 

Being confident with possessing the first-class technologies and platforms, strict quality management, 

SSR MedTech can provide the following services timely and efficiently to our clients:

  Lc-ms Method Development / Validation / Transfer and Optimization  

  Bioanalysis of Be Clinical Samples   

  Tk/Pk In Pre-clinical Phase or Bioanalysis for Drug Development   

1.jpg

Drug Metabolite Evaluation

Evaluation of drug metabolite has significant impact on drug safety and toxicity, and is one of keys for success in drug development. 

According to FDA guidance, the safety assessment should be conducted if a drug metabolite is 10% more of the total drug content. 

However, the qualitive and quantitative evaluation of a metabolite is a challenging task to analytical chemistry. 

Relying on its deep knowledgeable technical staff, and suitable instrumentation, 

SSR MedTech is able to provide our clients the following services:

  Identification of Metabolite and Metabolite Profiling  

  Identification of Metabolic Pathway  

  Inhibition/Inducing Assessment  

  Plasma Protein Binding  

  Metabolite Bioanalysis  


Bioanalysis of Pharmacodynamics (PD) Biomarkers

PD biomarker has become an important means to evaluate drug efficacy. As endogenous molecules, bioanalysis for PD 

biomarker is characteristically different from the approach for exogenous drugs. 

SSR MedTech provides routine biomarker bioanalysis, and also cable of developing bioanalytical methods for new 

biomarkers to meet clients’ specific needs in drug development.

  Protein Biomarkers  

  Peptide Biomarkers  

  Small Molecule Biomarkers 


Testing of Biomarkers in Clinical Diagnosis, Precision Medicine and Functional Medicine

  Testing of Hormone  

  New Born Screening  

  Treatment Drug Monitoring  

  Amino Acids Testing/Profiling

  Oligosaccharides Testing/Profiling  

  Testing of Vitamins (A, B, C, D, E)  

  Testing of Peptides and Proteins  


CopyRight © 2017-2027 中谱检测集团, All Right Reserved

恒网-承建